Neil E Wrigley Kelly1,2, Grace Kenny1,3, Féaron C Cassidy2,4, Alejandro A Garcia-Leon3, Conor De Barra2, Patrick W G Mallon1,3, Andrew E Hogan2,4, Donal O'Shea1. 1. St Vincent's University Hospital & University College Dublin, Dublin, Ireland. 2. Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Ireland. 3. Centre for Experimental Pathogen Host Research, School of Medicine, University College Dublin, Dublin, Ireland. 4. National Children's Research Centre, Dublin, Ireland.
Abstract
OBJECTIVE: Obesity is a major risk factor for severe disease in COVID-19, with increased hospitalization, intensive care unit admission, and mortality. This increased impact of COVID-19 in people with obesity (PWO) is likely driven, in part, by the well-described obesity-induced immune dysregulation. Obesity has also been associated with impaired immune memory in many settings, including weakened responses to hepatitis B, tetanus, rabies, and influenza vaccination. Recently, it was reported that PWO who have COVID-19 have reduced IgG antibody titers with defective neutralizing capabilities. However, it remains unknown whether PWO generate durable T cell immunity to SARS-CoV-2. METHODS: This study investigated SARS-CoV-2-specific T cell responses in a cohort of 40 patients (n = 20 PWO and n = 20 matched control individuals) who had recovered from COVID-19. T cell (CD4+ , CD8+ ) cytokine responses (IFNγ, TNFα) to SARS-CoV-2 peptide pools (spike, membrane) were determined using multicolor flow cytometry. RESULTS: Circulating T cells specific for SARS-CoV-2 were readily detected in the total cohort. PWO displayed comparable levels of SARS-CoV-2 spike- and membrane-specific T cells, with both T cell subsets responding. CONCLUSIONS: These data indicate that PWO who survive COVID-19 generate robust and durable SARS-CoV-2-specific T cell immunity that is equivalent to that seen in those without obesity.
OBJECTIVE: Obesity is a major risk factor for severe disease in COVID-19, with increased hospitalization, intensive care unit admission, and mortality. This increased impact of COVID-19 in people with obesity (PWO) is likely driven, in part, by the well-described obesity-induced immune dysregulation. Obesity has also been associated with impaired immune memory in many settings, including weakened responses to hepatitis B, tetanus, rabies, and influenza vaccination. Recently, it was reported that PWO who have COVID-19 have reduced IgG antibody titers with defective neutralizing capabilities. However, it remains unknown whether PWO generate durable T cell immunity to SARS-CoV-2. METHODS: This study investigated SARS-CoV-2-specific T cell responses in a cohort of 40 patients (n = 20 PWO and n = 20 matched control individuals) who had recovered from COVID-19. T cell (CD4+ , CD8+ ) cytokine responses (IFNγ, TNFα) to SARS-CoV-2 peptide pools (spike, membrane) were determined using multicolor flow cytometry. RESULTS: Circulating T cells specific for SARS-CoV-2 were readily detected in the total cohort. PWO displayed comparable levels of SARS-CoV-2 spike- and membrane-specific T cells, with both T cell subsets responding. CONCLUSIONS: These data indicate that PWO who survive COVID-19 generate robust and durable SARS-CoV-2-specific T cell immunity that is equivalent to that seen in those without obesity.
Authors: Patricia A Darrah; Dipti T Patel; Paula M De Luca; Ross W B Lindsay; Dylan F Davey; Barbara J Flynn; Søren T Hoff; Peter Andersen; Steven G Reed; Sheldon L Morris; Mario Roederer; Robert A Seder Journal: Nat Med Date: 2007-06-10 Impact factor: 53.440
Authors: Alon Eliakim; Christina Schwindt; Christina Swindt; Frank Zaldivar; Paolo Casali; Dan M Cooper Journal: Autoimmunity Date: 2006-03 Impact factor: 2.815
Authors: Gisella Guerrera; Mario Picozza; Silvia D'Orso; Roberta Placido; Marta Pirronello; Alice Verdiani; Andrea Termine; Carlo Fabrizio; Flavia Giannessi; Manolo Sambucci; Maria Pia Balice; Carlo Caltagirone; Antonino Salvia; Angelo Rossini; Luca Battistini; Giovanna Borsellino Journal: Sci Immunol Date: 2021-12-24
Authors: Eric J Nilles; Sameed M Siddiqui; Stephanie Fischinger; Yannic C Bartsch; Michael de St Aubin; Guohai Zhou; Matthew J Gluck; Samuel Berger; Justin Rhee; Eric Petersen; Benjamin Mormann; Michael Loesche; Yiyuan Hu; Zhilin Chen; Jingyou Yu; Makda Gebre; Caroline Atyeo; Matthew J Gorman; Alex Lee Zhu; John Burke; Matthew Slein; Mohammad A Hasdianda; Guruprasad Jambaulikar; Edward W Boyer; Pardis C Sabeti; Dan H Barouch; Boris Julg; Adam J Kucharski; Elon R Musk; Douglas A Lauffenburger; Galit Alter; Anil S Menon Journal: Viruses Date: 2021-11-06 Impact factor: 5.048
Authors: Barry M Popkin; Shufa Du; William D Green; Melinda A Beck; Taghred Algaith; Christopher H Herbst; Reem F Alsukait; Mohammed Alluhidan; Nahar Alazemi; Meera Shekar Journal: Obes Rev Date: 2020-08-26 Impact factor: 10.867
Authors: Carolyn Rydyznski Moderbacher; Sydney I Ramirez; Jennifer M Dan; Alba Grifoni; Kathryn M Hastie; Daniela Weiskopf; Simon Belanger; Robert K Abbott; Christina Kim; Jinyong Choi; Yu Kato; Eleanor G Crotty; Cheryl Kim; Stephen A Rawlings; Jose Mateus; Long Ping Victor Tse; April Frazier; Ralph Baric; Bjoern Peters; Jason Greenbaum; Erica Ollmann Saphire; Davey M Smith; Alessandro Sette; Shane Crotty Journal: Cell Date: 2020-09-16 Impact factor: 66.850
Authors: Neil E Wrigley Kelly; Grace Kenny; Féaron C Cassidy; Alejandro A Garcia-Leon; Conor De Barra; Patrick W G Mallon; Andrew E Hogan; Donal O'Shea Journal: Obesity (Silver Spring) Date: 2022-09-01 Impact factor: 9.298